Navigation Links
Clinical Trial Strategies to Ensure Pharmaceutical Success in a Global Marketplace
Date:11/16/2012

CHAPEL HILL, N.C., Nov. 16, 2012 /PRNewswire/ -- Pharmaceutical organizations are experiencing two dynamics in mature markets like North America and Europe: Clinical costs are continuing to rise and sales are either rising negligibly or not at all.

In emerging markets, meanwhile, the pharma sector is experiencing lower clinical costs and rapidly rising sales. While mature markets still represent a lion's share of most companies' sales, emerging markets represent significant cost savings and important future sales. And large countries like China and India are now requiring local clinical trials to win regulatory approvals to market products in those countries.

What this all adds up to is pharma organizations need to continue expansion of their clinical programs into emerging markets to cut costs and boost sales.

A study from Best Practices, LLC, Clinical Affairs Excellence: Benchmarking Clinical Roles and Trends for Pharmaceutical Success in a Global Marketplace, presents difficult to find metrics associated with outsourcing clinical trial activities – including cost, staffing, and quality. Best Practices®, LLC conducted this study to inform clinical affairs leaders at pharmaceutical companies on benchmarks around vendor selection, outsourcing attributes, desired competencies and outsourcing levels for key clinical functions, clinical affairs structure and outsourcing trends. In addition, the study presents qualitative insights from participants around outsourcing success factors and pitfalls.

Research participants included seven executives and managers from six pharma companies across a wide variety of therapeutic areas and product classes. In addition, four executive interviews were conducted to collect qualitative insights.

Specifically the study encompasses the following key topic areas: 

  • Vendor Selection and Outsourcing Attributes –-Presents benchmarks around selecting a vendor and the attributes of outsourcing.
  • CRA, CRM, and CRD Competencies & Outsourcing Levels– Presents benchmarks on desired competencies for CRAs, CRMs and CRDs and participants' outsourcing levels for these functions.
  • Clinical Affairs Organizational Fit –Highlights benchmarks around participants' organizational structure for Clinical Affairs.
  • Outsourcing Success Factors and Pitfalls – Provides participants' qualitative insights around outsourcing success factors and pitfalls.
  • Outsourcing Trends and Directions– Presents benchmarks on emerging trends for clinical activities in emerging areas of the world.
     

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1190.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
3. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
4. Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
5. AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
6. PRA Named Clinical Company of the Year in National Contest
7. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
8. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
9. 3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012
10. Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
11. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
(Date:6/24/2016)... ... 24, 2016 , ... Finally, a bruise cream that really works. Originally ... incorporated into the post-surgical treatment plans of a variety of other procedures including, but ... very effective for bruising and causes a rapid resolution of bruising and inflammatory changes ...
Breaking Medicine News(10 mins):